Full Citation
Wang J, Li X, Nicolas GM, Cai Y, Yuan T, Yan X, et al. Programmable viscoelastic hydrogels exhibit antimicrobial and regenerative properties to promote cell migration, wound healing, and tissue remodeling. Microsyst Nanoeng. 2026;12:151.
Background and Question
Chronic and complex wounds fail because the local matrix is mechanically abnormal, inflamed, microbially stressed, and poor at coordinating cell migration. Traditional dressings or single-factor scaffolds often address moisture or coverage but not the coupled mechanical and biological signals that guide epithelial, fibroblast, immune, and vascular behavior.
Research question
Can an engineered hydrogel reproduce key viscoelastic properties of native extracellular matrix while also supporting antimicrobial defense, cell migration, bioprinting, and tissue remodeling?
Methods and Evidence Chain
Built HA-gel-dex hydrogels from hyaluronic acid, gelatin, and dextran using irreversible amide bonds plus dynamic imine crosslinks.
Adjusted HA-gel to dex-CHO ratios and peptide functionalization to tune viscoelasticity, yield behavior, and bioprinting performance.
Assessed cell migration, regenerative behavior, antimicrobial properties, and wound/tissue-remodeling performance.
Linked chemical network architecture to matrix mechanics, then linked matrix mechanics to cellular repair phenotypes.
Material design
Built HA-gel-dex hydrogels from hyaluronic acid, gelatin, and dextran using irreversible amide bonds plus dynamic imine crosslinks.
Tuning strategy
Adjusted HA-gel to dex-CHO ratios and peptide functionalization to tune viscoelasticity, yield behavior, and bioprinting performance.
Biological assays
Assessed cell migration, regenerative behavior, antimicrobial properties, and wound/tissue-remodeling performance.
Evidence logic
Linked chemical network architecture to matrix mechanics, then linked matrix mechanics to cellular repair phenotypes.
Key Results
The hydrogel platform allowed broad viscoelastic tuning, including very high yield-ratio behavior reported by the authors.
Optimized matrices promoted cell migration and tissue-remodeling features consistent with a pro-repair microenvironment.
Antimicrobial properties add a clinically important layer for contaminated or high-risk wounds.
Bioprinting predictability suggests use as a printable wound bed, tissue model, or drug/cell delivery substrate.
Mechanism Interpretation
The central mechanism is not a single drug target. It is matrix instruction: dynamic imine bonds dissipate stress and allow remodeling, stable amide bonds preserve scaffold integrity, HA and gelatin provide ECM-like biochemical cues, and dextran-derived network tuning controls printability and cellular traction. Together these properties can reduce mechanical mismatch, permit migration, and support organized remodeling.
Mechanism / workflow schematic
Mermaid source is included so the website can render the diagram in supported browsers.
flowchart LR A[HA + gelatin + dextran chemistry] --> B[Stable amide network] A --> C[Dynamic imine crosslinks] B --> D[Scaffold integrity] C --> E[Stress relaxation and remodeling] D --> F[Printable wound matrix] E --> G[Cell migration] F --> H[Antimicrobial regenerative wound interface] G --> H
Clinical and Translational Relevance
Clinical relevance
For plastic surgery, the work is relevant to chronic wound beds, graft recipient-site preparation, tissue-engineered coverage, and postoperative wounds where mechanics and microbial burden shape outcomes. It is still preclinical, so it should be read as a platform paper rather than immediate practice-changing evidence.
Translational value
The platform is attractive because it can be tuned for different wound states: softer matrices for migration, stronger matrices for structural filling, antimicrobial variants for contaminated fields, and printable forms for patient-specific defects.
Limitations and Critique
No prospective human wound-healing trial is available from this report.
Material performance and repair surrogates are strong early signals but do not prove durable scar quality or functional recovery.
Sterility, batch reproducibility, degradation products, and storage stability need regulatory-grade characterization.
The best first clinical indication remains undefined: donor site, diabetic ulcer, burn wound, traumatic defect, or surgical dehiscence.
Reviewer-style critique
This is a high-value biomaterials paper because it frames wound healing as a mechanical-biological system, not simply as growth-factor delivery. The main weakness is the translational gap: sophisticated scaffold mechanics can look convincing in model systems while failing under real wound heterogeneity, exudate, bacterial biofilm, ischemia, and patient comorbidity.
Practical Next Research Actions
Action 1
Benchmark the hydrogel against standard dressings in diabetic and ischemic wound models with blinded histology.
Action 2
Measure macrophage polarization, angiogenesis, collagen organization, and re-epithelialization as a single repair panel.
Action 3
Test loading with antibiotics, exosomes, or antifibrotic agents while preserving viscoelastic behavior.
Action 4
Design a plastic-surgery pilot around donor-site pain, epithelial closure time, infection, and scar-quality endpoints.
Evidence-quality judgment
Moderate preclinical/translational evidence: mechanistically coherent and open access, but not yet clinical efficacy evidence.